Mortality News and Research

RSS

Babies born in cities face increased risk of death

Babies born in cities are surprisingly at increased risk of death in their first month of life compared with their counterparts in rural areas in Tanzania, a study says.

18 Jan 2022

Study finds improved survival rates for extremely preterm infants born in NIH-funded research network

The survival rate of extremely preterm infants born from 2013 through 2018 in a large network of U.S. research centers improved to 78.3%, compared to 76% for infants born in the network from 2008 to 2012, according to researchers funded by the National Institutes of Health.

18 Jan 2022

New findings support the routine use of remdesivir in hospitalized COVID-19 patients

Remdesivir, an antiviral drug used to treat COVID-19, increased the likelihood of clinical improvement in COVID-19 patients on low-flow oxygen or no oxygen, according to a new study authored by the Johns Hopkins University School of Medicine, the Johns Hopkins Bloomberg School of Public Health, HCA Healthcare, and Genospace.

18 Jan 2022

Exploring the waning effect of mRNA vaccines against COVID-19 in the elderly

In a new study, researchers determined the vaccine effectiveness against SARS-CoV-2 in older individuals.

18 Jan 2022

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

In this study, the researchers not only elucidate the recent bioconjugated nanomaterials for targeted diagnosis of SARS-CoV-2, but they also provide the rationale behind these developments by discussing the mechanisms and approaches.

18 Jan 2022

Forecasting the temporal evolution of Omicron infections

In a new study, researchers estimated the rate of SARS-CoV-2 Omicron infections by modeling temporal evolution of the Omicron wave.

18 Jan 2022

Machine learning model for prediction of COVID-19 patient mortality risk

A new preprint reports a novel machine learning model that purportedly predicts the mortality risk of COVID-19 in patients accurately and at an early stage of infection.

18 Jan 2022

An alternative mouse model of SARS-CoV-2 infection

Recently, a study has shown the possibility of repurposing hACE2 transgenic mice, primarily raised to study SARS-CoV, to support SARS-CoV-2 infection and pathogenesis.

17 Jan 2022

DPP4 protein: The connection between severe COVID-19 and diabetes

Researchers explore the relationship between DPP4 and diabetes targets in the management of COVID-19.

17 Jan 2022

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Researchers prevent evidence on the efficacy of neutralizing monoclonal antibodies in treating COVID-19.

17 Jan 2022

South African study confirms SARS-CoV-2 Omicron less severe than Delta even for unvaccinated

Researchers compare the outcomes of the fourth and previous waves of the COVID-19 pandemic in South Africa.

17 Jan 2022

Study shows how sex disparities in COVID-19 mortality varied over time in New York

Researchers analyze the variation in COVID-19 mortality by sex across six different periods during the pandemic in New York.

17 Jan 2022

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

Researchers investigate the efficacy of hydroxychloroquine and chloroquine in the treatment of patients hospitalized with COVID-19.

17 Jan 2022

Topical antiseptic Acriflavine inhibits SARS-CoV-2 and other betacoronaviruses

A new study, published in the journal Cell Chemical Biology, has reported the discovery of acriflavine (ACF), an effective inhibitor of SARS-CoV-2. This drug is a mixture of trypaflavines (3,6-diamino-10-methylacridinium chloride and 3,6-diamino-3-methylacridinium chloride) and proflavine (3,6-diaminoacridine).

16 Jan 2022

Study shows Omicron less severe than Delta among COVID-19 hospitalized patients

New research posted to the medRxiv* preprint server suggests the Omicron variant produces less severe COVID-19 symptoms than earlier severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants.

16 Jan 2022

Naïve T cells suggested as critical to low mortality of children with COVID-19

A new study discusses how naïve T cells may contribute to lower mortality rates seen in children with COVID-19.

14 Jan 2022

Similarities and dissimilarities in immune responses and metabolism in SARS-CoV-2 and HIV-1 infections

A new study, posted to the bioRxiv* preprint server, has developed a single-cell atlas that presents the shared and distinct immune responses and metabolism following SARS-CoV-2 and HIV-1 infections.

13 Jan 2022

Higher olive oil intake may reduce the risk of premature death

People who consume higher amounts of olive oil may lower their risk of premature death overall and from specific causes including cardiovascular disease, cancer, and neurodegenerative disease, compared to people who never or almost never consume olive oil, according to a new study led by researchers from Harvard T.H. Chan School of Public Health.

13 Jan 2022

Researchers implement and evaluate an educational intervention for prostate cancer

Prostate cancer is the second deadliest cancer in men in the United States. The incidence of prostate cancer in Black men is nearly 60% greater than the incidence in white men.

13 Jan 2022

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Researchers determine whether sequences within SARS-CoV-2 could lead to an immune response to autoantigens associated with autoimmune myocarditis.

13 Jan 2022

Mortality News and Research

Babies born in cities face increased risk of death

Study finds improved survival rates for extremely preterm infants born in NIH-funded research network

New findings support the routine use of remdesivir in hospitalized COVID-19 patients

Exploring the waning effect of mRNA vaccines against COVID-19 in the elderly

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

Forecasting the temporal evolution of Omicron infections

Machine learning model for prediction of COVID-19 patient mortality risk

An alternative mouse model of SARS-CoV-2 infection

DPP4 protein: The connection between severe COVID-19 and diabetes

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

South African study confirms SARS-CoV-2 Omicron less severe than Delta even for unvaccinated

Study shows how sex disparities in COVID-19 mortality varied over time in New York

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

Topical antiseptic Acriflavine inhibits SARS-CoV-2 and other betacoronaviruses

Study shows Omicron less severe than Delta among COVID-19 hospitalized patients

Naïve T cells suggested as critical to low mortality of children with COVID-19

Similarities and dissimilarities in immune responses and metabolism in SARS-CoV-2 and HIV-1 infections

Higher olive oil intake may reduce the risk of premature death

Researchers implement and evaluate an educational intervention for prostate cancer

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News